Bullish option flow detected in Crispr Therapeutics (CRSP) with 3,137 calls trading, 1.3x expected, and implied vol increasing almost 2 points to 57.05%. Jan-26 100 calls and Jan-26 60 calls are the most active options, with total volume in those strikes near 950 contracts. The Put/Call Ratio is 0.10. Earnings are expected on February 19th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Cathie Wood’s ARK Investment bought 58K shares of Crispr Therapeutics today
- Crispr Therapeutics call volume above normal and directionally bullish
- Crispr Therapeutics presents data on CTX112 at ASH Meeting
- Biotech Alert: Searches spiking for these stocks today
- CRISPR Therapeutics (NASDAQ:CRSP) Boasts Solid Potential and Limited Risk